The effects of treatments with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide in darkness and in light on survival and progression in Chinese hamster ovary cells in vitro.
نویسندگان
چکیده
The cytotoxic action of 5-(3,3-dimethyll-triazeno)imidazole-4-carboxamide in Chinese hamster ovary cells is enhanced considerably in the presence oflight, when 5-diazoimidazole-4-carboxamide is being continu ously generated. A broad shoulder threshold-type survival curve is seen when the cells are exposed to 5-(3,3-dimethyll-triazeno)imidazole-4-carboxamide (both in light anddark). The drug had only slight effects on the survival of cells treated in the dark for short times throughout the cell cycle. However, cells in the G! and early S phases were slightly more sensitive when treated with the drug in the light. Both light and dark treatments with the drug caused progression delay in S phase. Treatment in the light delayed cells at the G2-M boundary, whereas dark treatments delayed cells at the S-G2 boundary. Both light and dark treatments with the drug caused some G! cells to progress into S phase 1 hr early, while another fraction of the same population was delayed in G! phase.
منابع مشابه
Selective toxicity of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide toward hypoxic mammalian cells.
The chemotherapeutic agent 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) is used in the treatment of malignant melanoma where response rates of 15 to 30% have been reported. Some current interest exists in combining DTIC chemotherapy with localized high-dose (800 rads)-per-fraction radiotherapy in the treatment of unresectable metastatic melanoma. The present work investigates the ...
متن کاملSelective Toxicity of 5-(3,3-Dimethyl-1-triazeno)imidazole-4- carboxamide toward Hypoxie Mammalian Cells1
The chemotherapeutic agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC) is used in the treatment of malignant melanoma where response rates of 15 to 30% have been reported. Some current interest exists in combining DTIC chemotherapy with localized high-dose (800 rads)-per-fraction radiotherapy in the treatment of unresectable metastatic mel anoma. The present work investigates the ...
متن کاملFate of the ring moiety of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide in mammalian cells.
i/i vivo and in vitro (3, 9, 10). Clinically, it has been particularly useful in the treatment of malignant melanoma (1, 4). The antineoplastic action of DIC appears to be the result of more than one inhibitory mechanism. Degradation or trans formation of the drug can occur by at least 2 different routes, each producing a highly reactive molecular species. The 1st of these (Chart 1) involves th...
متن کاملMethylation of cysteine in hemoglobin following exposure to methylating agents.
In addition to reacting with biologically important nucleophilic sites in DNA, alkylating agents also interact with amino acids in proteins. Measurements of the extent of formation of these alkyl amino acids may be used as a means of determining exposure to these compounds. The degree of S-methylation of cysteine in hemoglobin was studied following in vivo exposure of rats to methyl methanesulf...
متن کاملFate of the Ring Moiety of 5-(3,3-Dimethyl-l-triazeno)imidazole- 4-carboxamide in Mammalian Cells1 •¿
i/i vivo and in vitro (3, 9, 10). Clinically, it has been particularly useful in the treatment of malignant melanoma (1, 4). The antineoplastic action of DIC appears to be the result of more than one inhibitory mechanism. Degradation or trans formation of the drug can occur by at least 2 different routes, each producing a highly reactive molecular species. The 1st of these (Chart 1) involves th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Cancer research
دوره 34 8 شماره
صفحات -
تاریخ انتشار 1974